Waiting list pressures at Oxford University Hospitals NHS Trust have resulted in a £10.7m overspend for Oxfordshire clinical commissioning group in the financial year to October 2013.
Elective over-performance and non-elective over performance have contributed to a year to date deficit of £5.2m for the commissioning group against a year to date plan for a £1.9m surplus.
25 November 2013
An estimated extra quarter of a million patients a year could be referred to the private sector under new waiting list rules, HSJ analysis has revealed.
WINNER: Roche Diagnostics and Oxford Academic Health Science Network: Changing clinical practice
WINNER: Gilead Sciences, CGL and the NHS: Gilead partnering with Drug Treatment Services (and the NHS) to support eliminating Hepatitis C (HCV)
An independent review has recommended Jeremy Hunt knocks back an NHS decision to downgrade a general hospital’s maternity services.
Oxfordshire Clinical Commissioning Group has hired an interim chief executive and will not seek a permanent replacement for the outgoing accountable officer until next year.
A new legal hearing has been granted into the proposed downgrade of an Oxfordshire hospital.
No comments yet